Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study.

Date publication

janvier 2025

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MAYNADIE Marc

Tous les auteurs :
Vener C, Lillini R, De Angelis R, Bonfarnuzzo S, Poirel HA, Trama A, Visser O, Troussard X, Marcos-Gragera R, Maynadié M, Demuru E, Di Benedetto C, Johannesen TB, Solans M, Paapsi K, Guevara M, Mousavi SM, Blum M, Von Moos R, Bennett D, Ragusa R, Guilloteau A, McShane CM, Rossi S, Sant M,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40056559

Résumé

EUROCARE, a European population-based cancer project, has shown geographical survival disparities for myeloid neoplasms (MN) suggesting healthcare inequalities. Total National Health Expenditure (TNHE) might influence population-based MN survival. We studied the long-term survival of 15 MN and the TNHE impact on prognosis between European countries.

Mots clés

Cancer registries, Europe, Myeloid neoplasms, Population-based studies, Real-world data, Survival, Total National Health Expenditure

Référence

Eur J Cancer. 2025 01 16;220:115231